28.11.2012 Views

inTervieW - Green Cross Publishing

inTervieW - Green Cross Publishing

inTervieW - Green Cross Publishing

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

34<br />

portions of the cerebral arteries and dura. This<br />

mediates a local inflammatory reaction (plasma<br />

extravasation) which in turn stimulates painful<br />

sensory receptors located on the cerebral<br />

arteries. The sensory afferent painful information<br />

is relayed along the ophthalmic division of the<br />

trigeminal nerve and synapses in the trigeminal<br />

nucleus caudalis in the brainstem (pons). Second<br />

order neurones further relay this information<br />

to the thalamus and third neurones relay the<br />

information to the higher cortical functions in the<br />

brain where pain is perceived.<br />

In addition, at the trigeminal nucleus caudalis<br />

(TnC) in the pons, there is an inter-neuronal<br />

connection between the TnC and superior<br />

salivatory nucleus and this results in activation of<br />

the cranial parasympathetic system which travels<br />

via the greater petrosal, a branch of the 7th<br />

cranial nerve, thus explaining the secreto-motor<br />

symptoms seen in cluster headache (trigeminalautonomic<br />

reflex). The partial Horner’s syndrome<br />

which completes the symptoms and signs is<br />

postulated to be due to sympathetic dysfunction<br />

caused by internal carotid dilatation as it<br />

traverses the cavernous sinus.1<br />

It is prudent that all patients who present with<br />

cluster headaches should be investigated and<br />

have MRI neuroimaging for potential secondary<br />

causes such as an internal carotid artery<br />

aneurysm or lateral protrusion of a pituitary<br />

macroadenoma into the cavernous sinus, both of<br />

which can mimic this disorder.<br />

case sTudy<br />

pRoducT news<br />

new Toleriane Teint Mineral Compact<br />

– for intolerant normal/combination<br />

sensitive skin<br />

nearly 60 per cent of women encounter skin discomfort and claim to<br />

have sensitive skin and of those, 30 per cent of women have skin which is<br />

sensitive to make-up. Skincare expert la Roche-Posay recenty launched new<br />

Toleriane Teint Mineral Compact for sensitive skin available in pharmacies<br />

nationwide from October. la Roche-Posay has created a new generation of<br />

foundation for women with sensitive, normal/combination or oily skin who<br />

find covering skin’s irregularities difficult.<br />

Sensitive skin with imperfections requires a foundation which provides<br />

good coverage whilst looking natural and respecting the skin’s fragility.<br />

la Roche-Posay’s expertise in foundations coupled with their skincare<br />

knowledge guarantee maximum tolerance along<br />

with unique make-up know-how.<br />

Women with these skin types (norm/comb<br />

or oily) often find that foundation is shiny and<br />

does not stay on throughout the day. They also<br />

notice that foundations can suffocate skin<br />

or aggravate imperfections. nEW Toleriane<br />

Teint Mineral offers the high coverage of<br />

a corrective foundation with the purifying<br />

properties of a mineral powder in a compact.<br />

It covers imperfections and mattifies the skin<br />

without blocking the pores whilst improving<br />

skin health. It has a buildable coverage for a<br />

perfectly corrected complexion with a natural<br />

long-lasting finish. Following one month of use, results<br />

showed a reduction in imperfections and improved complexion.<br />

TreaTMenT<br />

For over a generation, neurologists have been<br />

using oxygen therapy in the management of the<br />

acute attack. Oxygen therapy has established<br />

itself as a first-line agent and treatment of choice.<br />

The mode of delivery and action is unique to<br />

cluster headache and should be administered as<br />

100 per cent oxygen through a non re-breathing<br />

mask at a high flow rate of 7-10 litres per minute<br />

for 15 minutes.<br />

The efficacy of this treatment has, up to<br />

recently, been anecdotal with up to 70 per cent<br />

of cluster patients getting relief of their headache<br />

and associated symptoms within 10-15 minutes.<br />

A pivotal study by Goadsby et al was published<br />

in JAMA in December 2009 confirming and<br />

validating the use of oxygen therapy.2<br />

The mode of action of oxygen therapy is now<br />

better understood and it is postulated that it<br />

inhibits trigeminovascular and parasympathetic<br />

activation. This inhibition is concentrated at<br />

the superior salivatory nucleus where there is<br />

suppression of parasympathetic nerve fibre<br />

transmission in those fibres travelling via the<br />

greater petrosal nerve.<br />

The only pharmaceutical agent which<br />

has proven efficacy for the acute attack is<br />

subcutaneous sumatriptan 6mg, the triptan<br />

therapy (5-HT-1B/1D receptor agonist). This<br />

parenteral medication is not licensed in Ireland<br />

and is only available on a named patient basis. Its<br />

efficacy is similar to oxygen. nasal sumatriptan<br />

issue 10 volume 12 • novemBeR 2010<br />

has also demonstrated a benefit but has a slower<br />

onset of action. 3<br />

All narcotic agents and other analgesics have<br />

no role in the management of the acute attack.<br />

They have no proven efficacy and this case study<br />

bears testament to this. In addition their habitual<br />

use predisposes the patient to developing<br />

chronic daily headache and medication overuse<br />

headache.<br />

The calcium antagonist, verapramil, is the<br />

treatment of choice as a preventive therapy.<br />

There are many randomised and nonrandomised<br />

clinical trials proving its efficacy. It<br />

can be commenced at a dose of 80mg tds and<br />

titrated upwards if required. Some patients need<br />

to go up to a dose of 480mg. Patients should<br />

be monitored at the higher doses as verapramil<br />

can prolong the PR interval and patients should<br />

have an ECG prior to commencement. Verapramil<br />

blocks the entry of calcium into smooth muscle,<br />

reducing blood vessel dilatation which is<br />

responsible for the severe pain. Patients achieve<br />

a reduction in cluster headache days and the<br />

number of attacks per day.4<br />

references<br />

1. Journal of Headache and Facial Pain. Sept 2009<br />

1131-43.<br />

2. Journal of the American Medical Association.<br />

December 2009.<br />

3. Journal of neurology 2003. 630-33.<br />

4. Headache 2009. 117-25.<br />

Panadol Extra Soluble 24s – 30 per cent<br />

more powerful*<br />

Ireland’s no.1 brand of pain reliever** has introduced Panadol Extra Soluble<br />

Tablets this month. Pharmacy only Panadol Extra Soluble provides your<br />

customers with a non-codeine solution for pain relief. Panadol Extra Soluble<br />

Tablets 24s contains 500mg paracetamol plus 65mg caffeine in a soluble<br />

format – the fastest growing format***. The product is available as from<br />

October 14 th and will be supported by a heavy weight TV campaign and<br />

in-store POS.<br />

*when compared to standard paracetamol, Panadol Extra Soluble can give<br />

30 per cent more pain relieving power<br />

**Source: IMS & nielsen June 2010<br />

***IMS OTCIRl MAT Aug 2010<br />

www.yourmedicines.ie

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!